Illinois Municipal Retirement Fund’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.44M Buy
30,919
+909
+3% +$43.7K 0.02% 769
2026
Q1
$1.55M Buy
30,010
+86
+0.3% +$4.38K 0.02% 682
2025
Q4
$1.49M Buy
29,924
+1,368
+5% +$66.5K 0.02% 696
2025
Q3
$1.36M Buy
28,556
+108
+0.4% +$4.35K 0.02% 740
2025
Q2
$897K Buy
28,448
+145
+0.5% +$4.65K 0.01% 909
2025
Q1
$927K Sell
28,303
-730
-3% -$25.9K 0.01% 934
2024
Q4
$1.05M Sell
29,033
-3,180
-10% -$112K 0.01% 932
2024
Q3
$1M Buy
32,213
+2,431
+8% +$75.9K 0.01% 943
2024
Q2
$797K Buy
29,782
+156
+0.5% +$4.52K 0.01% 1020
2024
Q1
$1.01M Sell
29,626
-3,204
-10% -$95.4K 0.02% 910
2023
Q4
$950K Buy
32,830
+1,727
+6% +$45.8K 0.02% 917
2023
Q3
$858K Buy
+31,103
New +$947K 0.02% 909

Other funds holding SUPN

Illinois Municipal Retirement Fund's SUPN Position: Q2 2026 in Review

Illinois Municipal Retirement Fund increased its Supernus Pharmaceuticals (SUPN) stake by 3% in Q2 2026, buying an estimated $43.7K and bringing the position to 30,919 shares worth $1.44M. The position accounts for 0.02% of the portfolio, ranked #769.

Illinois Municipal Retirement Fund first reported a position in SUPN in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.55M in Q1 2026. 334 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • Illinois Municipal Retirement Fund held 30,919 shares of Supernus Pharmaceuticals worth $1.44M as of Q2 2026.
  • Illinois Municipal Retirement Fund bought 909 Supernus Pharmaceuticals shares in Q2 2026, an estimated $43.7K.
  • Supernus Pharmaceuticals made up 0.02% of Illinois Municipal Retirement Fund's portfolio in Q2 2026, its #769 holding.
  • Illinois Municipal Retirement Fund first reported a position in Supernus Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
  • Illinois Municipal Retirement Fund's Supernus Pharmaceuticals position peaked at $1.55M in Q1 2026.
  • 334 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Illinois Municipal Retirement Fund's 13F filing for Q2 2026, filed 12 Aug 2026.